List of communications


A novel integrative network model identifies ANXA2 as an epigenetically controlled driver of mesenchymal signature in glioblastoma.

Oral communication Roberto Ferrarese

Alternative splicing of BAF45d contributes to the pathogenesis of GBM

Oral communication marta alonso

Analyzing emergent behaviour in cellular automaton models of glioma invasion

Oral communication Andreas Deutsch

Annexin A2 is a key determinant of GBM aggressiveness by controlling cancer cell dissemination and proliferation.

Oral communication Francesca Maule

Apelin signaling controls glioblastoma neo-vascularization

Oral communication Kälin Roland

Clinical and molecular factors predict survival after surgery for recurrent glioblastoma multiforme

Oral communication Ángel R. De Lope

Clinical and Molecular features of Long-term Survivors with glioblastoma

Oral communication Barbara Melendez

Control of the redox balance in glioblastoma multiforme: impact on tumor metabolism, neovascularization and inflammation

Oral communication Mario Duran-Prado

Cortical plasticity catalysed by a prehabilitation protocol enables extensive resection of brain tumours in eloquent areas

Oral communication Juan Antonio Barcia

Early GBM Detection by Active-Feedback MRI

Oral communication Yung-Ya Lin

EF-14 Study : Efficacy of alternating electrical fields combined with Temozolomide vs Temozolomide alone in patients with newly diagnosed GBM

Oral communication Andreas Hottinger

Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions

Oral communication Olivier Saut

Endothelial apelin employs APJ and GP130 to sustain glioblastoma stem cells

Oral communication Julie Gavard

Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells.

Oral communication Elizabeth Stoll

Glioblastoma and the blood-brain barrier: Please do not neglect.

Oral communication Olaf van Tellingen

Glioblastoma as a disease of asymmetric cell division

Oral communication Ian Lorimer

Glioblastoma brain cancer invasion: how different subclasses move through the brain

Oral communication Geraldine O'Neill

Hybrid cellular automaton model of tumour growth

Oral communication Y. Admiralskiy

Identification of miR21 and miR210 as biomarkers of aggressive clinical behaviour in glioblastoma.

Oral communication Paola Parrella

Inhibition of Multidrug Resistance Protein I (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

Oral communication Amanda Tivnan

Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.

Oral communication Philippe Schucht

Intravital imaging reveals local effects of biopsy on glioma cell migration

Oral communication Maria Alieva

Ionizing radiations sustain Glioblastoma cell dedifferentiation to a stem phenotype through Survivin

Oral communication Perrine Dahan

Mathematical models for glioma invasion: Multiscality, proliferation, and treatment

Oral communication Christina Surulescu

Medically induced euthyroid hypothyroxinemia may improve outcomes in glioblastoma (GBM) patients-an observational study

Oral communication Aleck Hercbergs Hercbergs

Mesenchymal transtion in glioblastoma is mediated by ZEB1 and contributes to tumor heterogeneity

Oral communication Frank Kruyt

Nanostructured microspheres for the controlled release of BMP-7 and the suppression of glioblastoma initiating cells

Oral communication Marcos Garcia-Fuentes

Netrin-1 induced activation of Notch signaling regulates glioblastoma cell pathogenity

Oral communication Irene Ylivinkka

Novel in-vitro biomimetic microfluidic device to resemble the glioblastoma microenvironment

Oral communication Luis J. Fernandez

OncoFinder, a family of new methods for the analysis of complex intracellular signaling networks and its applications to biomedicine, drug discovery and practical anticancer therapy of glioblastoma

Oral communication Anton Buzdin

Opioid pretreatment alters blood-brain barrier penetration of doxorubicin in animal models: new strategy and application in glioblastoma care

Oral communication Anna Lisa Iorio

Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy

Oral communication Aurélie Henry

Prognostic and predictive significance of geometric measures based on pretreatment T1+Gd MR images in glioblastoma multiforme

Oral communication Víctor M. Pérez-García

Quantitative models of low-grade glioma: from the laws of infiltration in diffuse gliomas to a model of radiotherapy

Oral communication Christophe Deroulers

Radiotherapy plus Concomitant Temozolomide in Primary Gliosarcoma

Oral communication Sebastian Adeberg

RanBP6 is a novel tumor suppressor that negatively regulates EGFR

Oral communication Barbara Oldrini

Reirradiation of relapsed Glioblastoma

Oral communication Anthony Falkov

Role of SOX9 in Glioblastoma

Oral communication Ander Matheu

Simultaneously targeting cell autonomous and non-cell autonomous oncogenic signaling in glioblastoma

Oral communication Sourav Ghosh

Superdiffusive dynamics of cancer cells

Oral communication Sergei Fedotov

Survival in glioblastoma patients is predicted by miR-340, that regulates key cancer hallmarks by inhibiting NRAS

Oral communication Danilo Fiore

Synaptogenesis to prevent glioblastoma-induced neurodegeneration

Oral communication Sergio Casas-Tinto

Temozolomide and valproic acid in combination with vinorelbine for treatment of pediatric high-grade gliomas: a prelliminary analysis of a study protocol

Oral communication Maurizio Lucchesi

The force at the tip - modelling tension and proliferation in sprouting angiogenesis

Oral communication Rui Travasso

The role of MDGI in gliomas

Oral communication Maija Hyvönen

Towards the utilization of cannabinoids as anti-cancer agents in gliomas

Oral communication Guillermo Velasco

Tumor-stroma interaction in glioma through proteomic approaches

Oral communication Kumar Somasundaram

Uncovering the action of Temozolomide in brain tumor cells

Oral communication Anna-Maria Barciszewska

Viable Therapy Strategies in a Spatial Mathematical Model of Glioma With Consideration of Oxygen Delivery

Oral communication Elena Fimmel

Wnt pathway intracellular effectors are key deciders of GBM cell phenotype and behaviour.

Oral communication Elena Rampazzo

ZBTB18 Methylation Promotes Mesenchymal Transformation in Glioblastoma

Oral communication Maria Stella Carro

A focus on Glioblastomamultiforme heterogeneity through a paired primary culture in-vitro model.

Poster Elisabetta Stanzani

A Functional Approach for Searching Biomarkers of Glioma.

Poster Alexey Kopylov

A mathematical model of low grade gliomas treated with temozolomide and its therapeutical implications.

Poster Magdalena Bogdańska

A Transcriptomic Signature Mediated by HOXA9 Promotes Human Glioblastoma Initiation, Aggressiveness and Resistance to Temozolomide

Poster Marta Pojo Pojo

Analysis of the transcriptional changes induced by DYRK1A inhibition in glioblastoma cells

Poster Paloma Fernández

Autocrine VEGFR1 and VEGFR2 signaling in glioblastoma

Poster Emese Szabo

Automatic Brain Tumor Image Analysis: Current status and opportunities

Poster Mauricio Reyes

Characterize the effect of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles (USPIOs) Uptake on Glioblastoma Multiforme (GBM) Biology

Poster Rosita Pang

Could p53 and RAS alterations be responsible for the progression of cerebellar glioblastomas?

Poster Vedrana Milinkovic

Crosstalk between tumour cells and blood vessel pericytes is central to glioblastoma malignancy

Poster Elisabetta Maria Caspani

D-aminoacid oxidase enzymatic therapy potentiates the effects of radiotherapy in glioblastoma primary cultures

Poster Maripaz Ventero Martin

Delta-24-RDG as an alternative therapeutic tool for pHGG/DIPG

Poster Naiara Martinez

Detection of IDH1 mutations within circulating EVs from GBM patients

Poster Susana Esteban Rubio

Differences in myeloid cell subfractions in human GBM microenvironment determine alternate proangiogenic phenotype

Poster Anne Blank

Differential impact of VEGF-A vs. dual Angiopoietin-2/VEGF-A blocking on the efficacy of radio- and chemotherapy in a glioblastoma model

Poster Gergely Solecki

Disparate radiation response of slow proliferating glioblastoma initiating cells

Poster Florian Siebzehnrubl

Effect of all-trans retinoic acid on the characteristics of human glioblastoma multiforme cell line U251

Poster Danijela Drakulic

Elucidating the role of SOX3 gene in glioblastoma multiforme cell lines

Poster Jelena Marjanovic Vicentic

Endothelial Secreted Factors Suppress Mitogen Deprivation-Induced Autophagy and Apoptosis in Glioblastoma Stem-Like Cells

Poster Eva Maria Galan-Moya

Engineering glioblastoma microenvironment in a chip to study cell response

Poster Jose Maria Ayuso Dominguez

EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas

Poster Idoya Zazpe

Expression patterns of multiple antigens evaluated by immunochemistry in individual glioblastoma patient samples.

Poster Michael Barish

Flow cytometry assessment of anti-CD133 antibodies in human glioblastoma multiforme cells

Poster Dilara Akcora Yildiz

Genetic characterization of glioblastoma stem cell heterogeneity

Poster Francesca Noemi Orzan

Glioblastoma cells extracelular vesicles can reach the bloodstream through an intact bloodbrain barrier

Poster Josefa Carrion-Navarro

Glioblastoma tissue-guided segmentation through unsupervised structured classification

Poster Javier Juan-Albarracín

Global expression analysis of microRNAs in Sox-2 positive glioblastoma stem-like cells

Poster Jiri Sana

Growth analysis and gene expression profiling of in vivo GBM xenografts transplanted into rats brain, targeted by CED and IP injection with bevacisumab, cetuximab and both

Poster Kristjan Välk

High levels of MKP1 correlate with a higher sensitivity to chemotherapy in Glioblastoma patients associated to a differentiation of the cancer stem cells

Poster Olatz Arrizabalaga Garde

High-grade Glioma molecular stratification.

Poster Antonio Zafra Villaverde

Identification of genes that modulate Temozolomide (TMZ) response

Poster Alvaro Curiel

In search of druggable targets for GBM amino acid metabolism

Poster Eduard Panosyan

In vitro glioblastoma model of multi-drug resistance as a tool for the development of new therapeutic strategies

Poster Ana Podolski-Renic

In vivo evidences for the therapeutic effectiveness of Dacomitinib in glioblastoma

Poster Carmen Ramirez

Loss of Function of Krüppel-like Factor 6 Promotes Nuclear Factor-kB Signaling in Glioblastoma

Poster Anie Priscilla Masilamani

Machine-Learning to Predict Survival in Glioblastoma based on Growth Kinetics

Poster Corbin Rayfield

Mesenchymal Activation Mediated by CXCL12 in the Sub-ventricular Zone Promotes Glioblastoma Resistance to Radiotherapy.

Poster Nicolas Goffart

MET inhibition overcomes radiation resistance of glioblastoma stem-like cells

Poster Francesca De Bacco

Modulation of the expression of extracellular matrix components in glioblastoma and neuroblastoma-derived stem cells

Poster Ana Rosa Rama

Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegative cell cultures of human glioblastoma

Poster Galina Pavlova

Multiscale modeling of palisade formation in gliobastoma multiforme

Poster Ignacio Ramis Conde


Poster Svetlana Gelperina

Next generation sequencing (NGS) apporach to investigate new mutations in pediatric glioblastomo multiforme

Poster Laura Giunti

Next generation sequencing identifies different gbm molecular patterns that correlate with clinical and radiological behavior

Poster Diana Cantero Montenegro

OncoFinder, a family of new methods for the analysis of complex intracellular signaling networks and its applications to biomedicine, drug discovery and practical anticancer therapy of glioblastoma

Poster Anton Buzdin

Osteopontin/SPP1 is overexpressed in glioblastoma and through distinct domains participates in glioma stem cell renewal and glioma-microenvironment interactions

Poster Karolina Stępniak

Parp targeting counteracts gliomagenesis through promotion of genomic instability in pten-mutant glioma and downregulation of survival pathways

Poster Jara Majuelos

PARP-1 as a cell cycle regulator – a new job for an old friend.

Poster Irene Golán

Phosphodiesterase type 5 regulates glioblastoma invasiveness

Poster Valeriana Cesarini

Preclinical test of dacomitinib, an irreversible EGFR inhibitor, confirms its effectiveness for glioblastoma.

Poster Pilar Mª Aguilera Sepúlveda

Predicting the responsiveness and sensitisation of glioma cells to TRAIL and temozolomide by systems modelling

Poster Brona Murphy

Prognostic and predictive significance of geometric measures from high resolution pretreatment T1+Gd MR images of glioblastoma multiforme

Poster Víctor M. Pérez-García

Project: The role of extracellular vesicles in Glioblastoma Multiforme (GBM) microenvironment modulation

Poster Luis Alberto Perez-Romasanta

Protein tyrosine phosphatase mRNA profiling reveals candidates impacting on glioma cell behavior.

Poster Annika Bourgonje

Protracted metronomic therapies for grade II gliomas: Theoretical proof of concept of a novel therapeutic strategy.

Poster Alicia Martínez-González

Relevance of pro-angiogenic factors secretion in glioblastoma patients

Poster Noemi García-Romero

Role of CD109 in glioma invasion

Poster Pauliina Filppu

Selective targeting of glioblastoma using folate-decorated nano-particulate cytochrome c drug constructs

Poster Lilia Kucheryavykh

Short and long transcripts variant of KRAS at 3'UTR region as genetic biomarkers in glioblastoma

Poster Samantha Messina

SOX9 regulates glioblastoma stem cell activity

Poster Paula Aldaz Donamaria

Targeted proteomic approaches to study the molecular signature of glioma stem cells.

Poster Carmen Gonzalez Tejedo

Targeting commonly abrogated pathways in GBM: co-inhibition of the PI3K, MAPK and RB pathways

Poster Mark de Gooijer

targeting the midkine / anaplastic lymphoma kinase axis as a therapeutic strategy in GBM

Poster Israel López Valero

Targeting the transforming growth factor-β pathway in glioblastoma

Poster Hannah Schneider

The aryl hydrocarbon receptor mediates integrin control of the TGF-β pathway

Poster Manuela Silginer

The influence of Coenzyme Q on temozolomide therapeutic efficacy in resistant rat C6 glioma

Poster Sonja Stojkovic

The interplay of Epsins and Notch in Glioblastoma

Poster Marina Cardano

The N-terminal tripeptide of IGF-I (GPE) stimulates the proliferation of 3T3 mouse embryo astrocytes

Poster Cristina Almengló Buzón

The use of Gliolan in intracranial gliomas resection.

Poster Mateusz Krakowiak

Threshold values and means of rCBV, ADC, Cho/Cr and Cho/NAA as imaging biomarkers for glioma grade and metastasis diagnosis: calculation based on systematic review and meta-analysis of clinical trials

Poster Rytė Rynkevičienė

Tumor-derived lactadherin as a potential factor responsible for pro-invasive polarization of glioma-associated microglia and macrophages

Poster Dominika Pszczółkowska

Update on Phase 1/2 study of VAL-083 (dianhydrogalactitol) in patients with recurrent malignant glioma

Poster Jeffrey Bacha

Organized by